Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates From New-Generation Transdermal Technology Using Large-Scale Human Testing and Machine Learning Algorithms

Part of paid clinical trials in Champaign, Illinois.

Sponsor
University of Illinois at Urbana-Champaign
Study ID
NCT05692830
Status
Recruiting
Apply to this trial

Conditions

  • Alcohol Drinking
  • Alcohol Intoxication

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Alcohol — DRUG
    Alcohol administered orally at multiple doses and consumption speeds to test transdermal device accuracy

Study Details

The study will employ a combined laboratory-ambulatory design. Participants will engage in ambulatory assessment over the course of 14 days, wearing biosensors assessing transdermal alcohol concentration (TAC) and providing breathalyzer readings in real-world contexts. Also during this period, participants will attend three laboratory alcohol-administration sessions scheduled at one-week intervals, with alcohol dose and rate of consumption manipulated within and between participants, respectively. Laboratory visits will also double as ambulatory orientation, check-in, and close-out sessions.

Key Dates

Start date
Oct 22, 2022
Status verified
Aug 2025
Primary completion
Aug 1, 2026
Completion
Sep 1, 2027

Study Design

Enrollment
240 participants (estimated)

Primary Outcome Measure

Transdermal estimates of alcohol consumption [ Time Frame: Across the 14 day period of the study ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Illinois at Urbana-ChampaignChampaignIllinois61820
Catharine E Fairbairn, Ph.D.
[email protected]
217 300 5850

Find similar trials in Champaign, IL

By research site
University of Illinois at Urbana-Champaign· Champaign, IL

Related Studies